Developing Medical Innovation

We manufacture new medical technologies from the NHS and beyond to improve patient care

Revolutionary new technologies

Medovate is a dynamic medical device company dedicated to manufacturing innovative new medical devices and bringing them to market to help improve patient care.

We work closely with NHS clinicians and professionals to take their innovative ideas for new medical devices through the full development cycle including manufacturing, regulatory compliance and market launch.

The Medovate team comprises dedicated and experienced professionals, representing a significant number of years collective knowledge and expertise acquired through working in the medical technologies sector.


** COVID-19 pandemic: Medovate continues to remain fully open during this time with staff enabled to work from home. Please continue to contact us via phone and e-mail.****

Read More
SAFIRA-in-action-1_cropped-for-product-carousel.jpg

Latest News

Keep up to date with Medovate News & Events

News

Queen Elizabeth Hospital King’s Lynn invented device SAFIRA® awarded HSJ Patient Safety Innovation of the Year

23rd September, 2021

Ground-breaking regional anaesthesia device, SAFIRA®, invented by clinicians at The Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust (QEH) and developed in conjunction with Medovate, has been awarded ‘Patient Safety Innovation of the Year’ at this year’s HSJ Patient Safety Awards.

News

Jim Beyer joins Medovate as US Commercial Executive Consultant

24th August, 2021

Medovate is pleased to announce that Jim Beyer is joining the team as US Commercial Executive Consultant to focus on positioning Medovate’s FDA cleared device SAFIRA™ (Safer Injection for Regional Anesthesia) throughout the United States to both national and regional Group Purchasing Organizations (GPO’s) and Integrated Delivery Networks (IDN’s).

News

Medovate expands SAFIRA® product range with further CE Mark Regulatory Approvals

16th August, 2021

Medovate announces it has successfully secured additional CE Mark Regulatory Approvals for its game-changing SAFIRA® (SAFer Injection for Regional Anaesthesia) technology to include an NRFit™ syringe and a Palm Operator.